(1 reference)-
- 抗原 See all CD161 (KLRB1) 抗体
- CD161 (KLRB1) (Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This CD161 antibody is un-conjugated
-
应用范围
- Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro))
- 产品特性
- Purified IgG
- 纯化方法
- Purified
- 克隆位点
- B199-2
- 亚型
- IgG1
- Top Product
- Discover our top product KLRB1 Primary Antibody
-
anti-Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1) (AA 73-188) antibody
KLRB1 适用: 人 WB, IP, IHC, ICC 宿主: 兔 Polyclonal unconjugated
anti-Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1) antibodyKLRB1 适用: 人, Non-Human Primate FACS, WB, IHC (fro) 宿主: 小鼠 Monoclonal HP-3G10 unconjugated
anti-Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1) antibody (PE)KLRB1 适用: 大鼠 FACS 宿主: 小鼠 Monoclonal 10-78 PE
anti-Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1) (AA 67-225) antibodyKLRB1 适用: 人 FACS, ELISA 宿主: 小鼠 Monoclonal 4C6A11 unconjugated
anti-Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1) (AA 151-225) antibodyKLRB1 适用: 人, 大鼠 ELISA 宿主: 兔 Polyclonal unconjugated
anti-Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1) antibodyKLRB1 适用: 大鼠 FACS, WB, IP, IHC (fro), RIA 宿主: 小鼠 Monoclonal 10-78 unconjugated
anti-Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1) antibody (FITC)KLRB1 适用: 大鼠 FACS 宿主: 小鼠 Monoclonal 10-78 FITC
anti-Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1) antibodyKLRB1 适用: 大鼠 FACS, WB, IP, IHC (fro), RIA 宿主: 小鼠 Monoclonal 10-78 unconjugated
anti-Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1) antibodyKLRB1 适用: 人 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Killer Cell Lectin-Like Receptor Subfamily B, Member 1 (KLRB1) (AA 126-225) antibodyKLRB1 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 2F3 unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1.0 mg/mL
-
-
: "Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and correlates with remission state." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 186, Issue 7, pp. 4490-9, (2011) (PubMed).
-
: "Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and correlates with remission state." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 186, Issue 7, pp. 4490-9, (2011) (PubMed).
-
-
You are here:
